| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |